1 Study Coverage 1.1 Efavirenz/Lamivudine/Tenofovir Compound Drugs Product Introduction 1.2 Market by Type 1.2.1 Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Market Size Growth Rate by Type 1.2.2 API Source: Self-Produce 1.2.3 API Source: Local Sources 1.2.4 API Source: Imported 1.2.5 Other 1.3 Market by Application 1.3.1 Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Market Size Growth Rate by Application 1.3.2 HIV Infection 1.3.3 Other 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Market Size, Estimates and Forecasts 2.1.1 Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue 2016-2027 2.1.2 Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales 2016-2027 2.2 Global Efavirenz/Lamivudine/Tenofovir Compound Drugs, Market Size by Region: 2016 VS 2021 VS 2027 2.3 Efavirenz/Lamivudine/Tenofovir Compound Drugs Historical Market Size by Region (2016-2021) 2.3.1 Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Efavirenz/Lamivudine/Tenofovir Compound Drugs Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Forecast by Region (2022-2027) 2.4.2 Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Forecast by Region (2022-2027) 3 Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Competitor Landscape by Players 3.1 Global Top Efavirenz/Lamivudine/Tenofovir Compound Drugs Manufacturers by Sales 3.1.1 Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales by Manufacturer (2016-2021) 3.1.2 Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Efavirenz/Lamivudine/Tenofovir Compound Drugs Manufacturers by Revenue 3.2.1 Key Efavirenz/Lamivudine/Tenofovir Compound Drugs Manufacturers Covered: Ranking by Revenue 3.2.2 Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue by Manufacturers (2016-2021) 3.2.3 Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue in 2020 3.2.6 Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Price by Manufacturers 3.4 Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Manufacturing Base Distribution, Product Types 3.4.1 Efavirenz/Lamivudine/Tenofovir Compound Drugs Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Efavirenz/Lamivudine/Tenofovir Compound Drugs Product Type 3.4.3 Date of International Manufacturers Enter into Efavirenz/Lamivudine/Tenofovir Compound Drugs Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Market Size by Type (2016-2021) 4.1.1 Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales by Type (2016-2021) 4.1.2 Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue by Type (2016-2021) 4.1.3 Efavirenz/Lamivudine/Tenofovir Compound Drugs Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Market Size Forecast by Type (2022-2027) 4.2.1 Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Forecast by Type (2022-2027) 4.2.2 Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Forecast by Type (2022-2027) 4.2.3 Efavirenz/Lamivudine/Tenofovir Compound Drugs Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Market Size by Application (2016-2021) 5.1.1 Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales by Application (2016-2021) 5.1.2 Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue by Application (2016-2021) 5.1.3 Efavirenz/Lamivudine/Tenofovir Compound Drugs Price by Application (2016-2021) 5.2 Efavirenz/Lamivudine/Tenofovir Compound Drugs Market Size Forecast by Application (2022-2027) 5.2.1 Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Forecast by Application (2022-2027) 5.2.2 Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Forecast by Application (2022-2027) 5.2.3 Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Price Forecast by Application (2022-2027) 6 China by Players, Type and Application 6.1 China Efavirenz/Lamivudine/Tenofovir Compound Drugs Market Size YoY Growth 2016-2027 6.1.1 China Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales YoY Growth 2016-2027 6.1.2 China Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue YoY Growth 2016-2027 6.1.3 China Efavirenz/Lamivudine/Tenofovir Compound Drugs Market Share in Global Market 2016-2027 6.2 China Efavirenz/Lamivudine/Tenofovir Compound Drugs Market Size by Players (International and Local Players) 6.2.1 China Top Efavirenz/Lamivudine/Tenofovir Compound Drugs Players by Sales (2016-2021) 6.2.2 China Top Efavirenz/Lamivudine/Tenofovir Compound Drugs Players by Revenue (2016-2021) 6.3 China Efavirenz/Lamivudine/Tenofovir Compound Drugs Historic Market Review by Type (2016-2021) 6.3.1 China Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Market Share by Type (2016-2021) 6.3.2 China Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Market Share by Type (2016-2021) 6.3.3 China Efavirenz/Lamivudine/Tenofovir Compound Drugs Price by Type (2016-2021) 6.4 China Efavirenz/Lamivudine/Tenofovir Compound Drugs Market Estimates and Forecasts by Type (2022-2027) 6.4.1 China Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Forecast by Type (2022-2027) 6.4.2 China Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Forecast by Type (2022-2027) 6.4.3 China Efavirenz/Lamivudine/Tenofovir Compound Drugs Price Forecast by Type (2022-2027) 6.5 China Efavirenz/Lamivudine/Tenofovir Compound Drugs Historic Market Review by Application (2016-2021) 6.5.1 China Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Market Share by Application (2016-2021) 6.5.2 China Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Market Share by Application (2016-2021) 6.5.3 China Efavirenz/Lamivudine/Tenofovir Compound Drugs Price by Application (2016-2021) 6.6 China Efavirenz/Lamivudine/Tenofovir Compound Drugs Market Estimates and Forecasts by Application (2022-2027) 6.6.1 China Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Forecast by Application (2022-2027) 6.6.2 China Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Forecast by Application (2022-2027) 6.6.3 China Efavirenz/Lamivudine/Tenofovir Compound Drugs Price Forecast by Application (2022-2027) 7 North America 7.1 North America Efavirenz/Lamivudine/Tenofovir Compound Drugs Market Size YoY Growth 2016-2027 7.2 North America Efavirenz/Lamivudine/Tenofovir Compound Drugs Market Facts & Figures by Country 7.2.1 North America Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales by Country (2016-2021) 7.2.2 North America Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Efavirenz/Lamivudine/Tenofovir Compound Drugs Market Size YoY Growth 2016-2027 8.2 Asia Pacific Efavirenz/Lamivudine/Tenofovir Compound Drugs Market Facts & Figures by Region 8.2.1 Asia Pacific Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales by Region (2016-2021) 8.2.2 Asia Pacific Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe Efavirenz/Lamivudine/Tenofovir Compound Drugs Market Size YoY Growth 2016-2027 9.2 Europe Efavirenz/Lamivudine/Tenofovir Compound Drugs Market Facts & Figures by Country 9.2.1 Europe Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales by Country (2016-2021) 9.2.2 Europe Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Efavirenz/Lamivudine/Tenofovir Compound Drugs Market Size YoY Growth 2016-2027 10.2 Latin America Efavirenz/Lamivudine/Tenofovir Compound Drugs Market Facts & Figures by Country 10.2.1 Latin America Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales by Country (2016-2021) 10.2.2 Latin America Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Efavirenz/Lamivudine/Tenofovir Compound Drugs Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Efavirenz/Lamivudine/Tenofovir Compound Drugs Market Facts & Figures by Country 11.2.1 Middle East and Africa Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales by Country (2016-2021) 11.2.2 Middle East and Africa Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 U.A.E 12 Company Profiles 12.1 Cipla 12.1.1 Cipla Corporation Information 12.1.2 Cipla Description and Business Overview 12.1.3 Cipla Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Cipla Efavirenz/Lamivudine/Tenofovir Compound Drugs Products Offered 12.1.5 Cipla Recent Development 12.2 Mylan 12.2.1 Mylan Corporation Information 12.2.2 Mylan Description and Business Overview 12.2.3 Mylan Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Mylan Efavirenz/Lamivudine/Tenofovir Compound Drugs Products Offered 12.2.5 Mylan Recent Development 12.3 MSD Pharmaceuticals 12.3.1 MSD Pharmaceuticals Corporation Information 12.3.2 MSD Pharmaceuticals Description and Business Overview 12.3.3 MSD Pharmaceuticals Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales, Revenue and Gross Margin (2016-2021) 12.3.4 MSD Pharmaceuticals Efavirenz/Lamivudine/Tenofovir Compound Drugs Products Offered 12.3.5 MSD Pharmaceuticals Recent Development 12.4 Sun Pharmaceutical Industries 12.4.1 Sun Pharmaceutical Industries Corporation Information 12.4.2 Sun Pharmaceutical Industries Description and Business Overview 12.4.3 Sun Pharmaceutical Industries Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Sun Pharmaceutical Industries Efavirenz/Lamivudine/Tenofovir Compound Drugs Products Offered 12.4.5 Sun Pharmaceutical Industries Recent Development 12.5 Hetero Drugs 12.5.1 Hetero Drugs Corporation Information 12.5.2 Hetero Drugs Description and Business Overview 12.5.3 Hetero Drugs Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Hetero Drugs Efavirenz/Lamivudine/Tenofovir Compound Drugs Products Offered 12.5.5 Hetero Drugs Recent Development 12.11 Cipla 12.11.1 Cipla Corporation Information 12.11.2 Cipla Description and Business Overview 12.11.3 Cipla Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Cipla Efavirenz/Lamivudine/Tenofovir Compound Drugs Products Offered 12.11.5 Cipla Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Efavirenz/Lamivudine/Tenofovir Compound Drugs Industry Trends 13.2 Efavirenz/Lamivudine/Tenofovir Compound Drugs Market Drivers 13.3 Efavirenz/Lamivudine/Tenofovir Compound Drugs Market Challenges 13.4 Efavirenz/Lamivudine/Tenofovir Compound Drugs Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Efavirenz/Lamivudine/Tenofovir Compound Drugs Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of API Source: Self-Produce Table 3. Major Manufacturers of API Source: Local Sources Table 4. Major Manufacturers of API Source: Imported Table 5. Major Manufacturers of Other Table 6. Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Market Size Growth Rate by Application (2021-2027) & (M Pcs) Table 7. Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Market Size by Region (M Pcs) & (US$ Million), 2016 VS 2021 VS 2027 Table 8. Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales by Regions (2016-2021) & (M Pcs) Table 9. Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Market Share by Regions (2016-2021) Table 10. Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue by Regions (2016-2021) & (US$ Million) Table 11. Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Forecast by Region (2022-2027) & (M Pcs) Table 12. Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Market Share Forecast by Region (2022-2027) Table 13. Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Forecast by Region (2022-2027) & (US$ Million) Table 14. Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Market Share Forecast by Region (2022-2027) Table 15. Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales by Manufacturers (2016-2021) (M Pcs) Table 16. Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Share by Manufacturers (2016-2021) Table 17. Ranking of Global Top Efavirenz/Lamivudine/Tenofovir Compound Drugs Manufacturers by Revenue (US$ Million) in 2020 Table 18. Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue by Manufacturers (2016-2021) (US$ Million) Table 19. Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Share by Manufacturers (2016-2021) Table 20. Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 21. Global Efavirenz/Lamivudine/Tenofovir Compound Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Efavirenz/Lamivudine/Tenofovir Compound Drugs as of 2020) Table 22. Key Manufacturers Efavirenz/Lamivudine/Tenofovir Compound Drugs Price (2016-2021) (USD/K Pcs) Table 23. Efavirenz/Lamivudine/Tenofovir Compound Drugs Manufacturers Manufacturing Base Distribution and Headquarters Table 24. Manufacturers Efavirenz/Lamivudine/Tenofovir Compound Drugs Product Type Table 25. Date of International Manufacturers Enter into Efavirenz/Lamivudine/Tenofovir Compound Drugs Market Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans Table 27. Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales by Type (2016-2021) (M Pcs) Table 28. Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Share by Type (2016-2021) Table 29. Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue by Type (2016-2021) (US$ Million) Table 30. Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Share by Type (2016-2021) Table 31. Efavirenz/Lamivudine/Tenofovir Compound Drugs Average Selling Price (ASP) by Type (2016-2021) & (USD/K Pcs) Table 32. Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Forecast by Type (2022-2027) & (M Pcs) Table 33. Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Market Share Forecast by Type (2022-2027) Table 34. Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Forecast V (2022-2027) & (US$ Million) Table 35. Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Market Share Forecast by Type (2022-2027) Table 36. Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/K Pcs) Table 37. Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales by Application (2016-2021) (M Pcs) Table 38. Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Share by Application (2016-2021) Table 39. Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue by Application (2016-2021) (US$ Million) Table 40. Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Share by Application (2016-2021) Table 41. Efavirenz/Lamivudine/Tenofovir Compound Drugs Average Selling Price (ASP) by Application (2016-2021) & (USD/K Pcs) Table 42. Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Forecast by Application (2022-2027) & (M Pcs) Table 43. Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Market Share Forecast by Application (2022-2027) Table 44. Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Forecast by Application (2022-2027) & (US$ Million) Table 45. Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Market Share Forecast by Application (2022-2027) Table 46. Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/K Pcs) Table 47. China Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales (M Pcs) of Key Companies (2016-2021) Table 48. China Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Share by Company (2016-2021) Table 49. China Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue (US$ Million) by Company (2016-2021) Table 50. China Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Share by Company (2016-2021) Table 51. China Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales (M Pcs) by Type (2016-2021) Table 52. China Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Share by Type (2016-2021) Table 53. China Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue (US$ Million) Market Share by Type (2016-2021) Table 54. China Efavirenz/Lamivudine/Tenofovir Compound Drugs Price (USD/K Pcs) by Type (2016-2021) Table 55. China Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales (M Pcs) by Type (2022-2027) Table 56. China Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Share by Type (2022-2027) Table 57. China Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue (US$ Million) Market Share by Type (2022-2027) Table 58. China Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Share by Type (2022-2027) Table 59. China Efavirenz/Lamivudine/Tenofovir Compound Drugs Price (USD/K Pcs) by Type (2022-2027) Table 60. China Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales (M Pcs) by Application (2016-2021) Table 61. China Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Share by Application (2016-2021) Table 62. China Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue (US$ Million) Market Share by Application (2016-2021) Table 63. China Efavirenz/Lamivudine/Tenofovir Compound Drugs Price (USD/K Pcs) by Application (2016-2021) Table 64. China Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales (M Pcs) by Application (2022-2027) Table 65. China Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Share by Application (2022-2027) Table 66. China Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue (US$ Million) Market Share by Application (2022-2027) Table 67. China Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Share by Application (2022-2027) Table 68. China Efavirenz/Lamivudine/Tenofovir Compound Drugs Price (USD/K Pcs) by Application (2022-2027) Table 69. North America Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales by Country (2016-2021) & (M Pcs) Table 70. North America Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Market Share by Country (2016-2021) Table 71. North America Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue by Country (2016-2021) & (US$ Million) Table 72. North America Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Market Share by Country (2016-2021) Table 73. Asia Pacific Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales by Region (2016-2021) & (M Pcs) Table 74. Asia Pacific Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Market Share by Region (2016-2021) Table 75. Asia Pacific Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue by Region (2016-2021) & (US$ Million) Table 76. Asia Pacific Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Market Share by Region (2016-2021) Table 77. Europe Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales by Country (2016-2021) & (M Pcs) Table 78. Europe Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Market Share by Country (2016-2021) Table 79. Europe Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue by Country (2016-2021) & (US$ Million) Table 80. Europe Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Market Share by Country (2016-2021) Table 81. Latin America Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales by Country (2016-2021) & (M Pcs) Table 82. Latin America Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Market Share by Country (2016-2021) Table 83. Latin Americaa Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue by Country (2016-2021) & (US$ Million) Table 84. Latin America Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Market Share by Country (2016-2021) Table 85. Middle East and Africa Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales by Country (2016-2021) & (M Pcs) Table 86. Middle East and Africa Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Market Share by Country (2016-2021) Table 87. Middle East and Africa Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue by Country (2016-2021) & (US$ Million) Table 88. Middle East and Africa Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Market Share by Country (2016-2021) Table 89. Cipla Corporation Information Table 90. Cipla Description and Business Overview Table 91. Cipla Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2016-2021) Table 92. Cipla Efavirenz/Lamivudine/Tenofovir Compound Drugs Product Table 93. Cipla Recent Development Table 94. Mylan Corporation Information Table 95. Mylan Description and Business Overview Table 96. Mylan Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2016-2021) Table 97. Mylan Product Table 98. Mylan Recent Development Table 99. MSD Pharmaceuticals Corporation Information Table 100. MSD Pharmaceuticals Description and Business Overview Table 101. MSD Pharmaceuticals Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2016-2021) Table 102. MSD Pharmaceuticals Product Table 103. MSD Pharmaceuticals Recent Development Table 104. Sun Pharmaceutical Industries Corporation Information Table 105. Sun Pharmaceutical Industries Description and Business Overview Table 106. Sun Pharmaceutical Industries Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2016-2021) Table 107. Sun Pharmaceutical Industries Product Table 108. Sun Pharmaceutical Industries Recent Development Table 109. Hetero Drugs Corporation Information Table 110. Hetero Drugs Description and Business Overview Table 111. Hetero Drugs Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales (M Pcs), Revenue (US$ Million), Price (USD/K Pcs) and Gross Margin (2016-2021) Table 112. Hetero Drugs Product Table 113. Hetero Drugs Recent Development Table 114. Efavirenz/Lamivudine/Tenofovir Compound Drugs Market Trends Table 115. Efavirenz/Lamivudine/Tenofovir Compound Drugs Market Drivers Table 116. Efavirenz/Lamivudine/Tenofovir Compound Drugs Market Challenges Table 117. Efavirenz/Lamivudine/Tenofovir Compound Drugs Market Restraints Table 118. Efavirenz/Lamivudine/Tenofovir Compound Drugs Customers List Table 119. Efavirenz/Lamivudine/Tenofovir Compound Drugs Distributors List Table 120. Research Programs/Design for This Report Table 121. Key Data Information from Secondary Sources Table 122. Key Data Information from Primary Sources List of Figures Figure 1. Efavirenz/Lamivudine/Tenofovir Compound Drugs Product Picture Figure 2. Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Market Share by Type in 2020 & 2027 Figure 3. API Source: Self-Produce Product Picture Figure 4. API Source: Local Sources Product Picture Figure 5. API Source: Imported Product Picture Figure 6. Other Product Picture Figure 7. Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Market Share by Application in 2020 & 2027 Figure 8. HIV Infection Figure 9. Other Figure 10. Efavirenz/Lamivudine/Tenofovir Compound Drugs Report Years Considered Figure 11. Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Market Size 2016-2027 (US$ Million) Figure 13. Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales 2016-2027 (M Pcs) Figure 14. Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Market Size Market Share by Region: 2021 Versus 2027 Figure 15. Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Market Share by Region (2016-2021) Figure 16. Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Market Share by Region in 2020 Figure 17. Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Market Share by Region (2016-2021) Figure 18. Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Market Share by Region in 2020 Figure 19. Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Share by Manufacturer in 2020 Figure 20. The Top 10 and 5 Players Market Share by Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue in 2020 Figure 21. Efavirenz/Lamivudine/Tenofovir Compound Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 22. Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Market Share by Type (2016-2021) Figure 23. Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Market Share by Type in 2020 Figure 24. Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Market Share by Type (2016-2021) Figure 25. Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Market Share by Type in 2020 Figure 26. Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Market Share by Application (2016-2021) Figure 27. Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Market Share by Application in 2020 Figure 28. Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Market Share by Application (2016-2021) Figure 29. Global Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Market Share by Application in 2020 Figure 30. China Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Growth Rate 2016-2027 (M Pcs) Figure 31. China Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Growth Rate 2016-2027 (US$ Million) Figure 32. China Efavirenz/Lamivudine/Tenofovir Compound Drugs Market Share in Global Market 2016-2027 Figure 33. China 5 and 10 Largest Efavirenz/Lamivudine/Tenofovir Compound Drugs Players Market Share by Revenue in Efavirenz/Lamivudine/Tenofovir Compound Drugs in 2020 Figure 34. China Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Share by Type (2016-2021) Figure 35. China Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Growth Rate by Type in 2016 & 2020 Figure 36. China Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Share by Application (2016-2021) Figure 37. China Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Growth Rate by Application in 2016 & 2020 Figure 38. North America Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Growth Rate 2016-2021 (M Pcs) Figure 39. North America Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Growth Rate 2016-2021 (US$ Million) Figure 40. North America Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Market Share by Country in 2020 Figure 41. North America Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Market Share by Country in 2020 Figure 42. U.S. Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Growth Rate (2016-2021) (M Pcs) Figure 43. U.S. Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Canada Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Growth Rate (2016-2021) (M Pcs) Figure 45. Canada Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Europe Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Growth Rate 2016-2021 (M Pcs) Figure 47. Europe Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Growth Rate 2016-2021 (US$ Million) Figure 48. Europe Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Market Share by Country in 2020 Figure 49. Europe Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Market Share by Country in 2020 Figure 50. Germany Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Growth Rate (2016-2021) (M Pcs) Figure 51. Germany Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 52. France Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Growth Rate (2016-2021) (M Pcs) Figure 53. France Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 54. U.K. Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Growth Rate (2016-2021) (M Pcs) Figure 55. U.K. Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 56. Italy Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Growth Rate (2016-2021) (M Pcs) Figure 57. Italy Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 58. Russia Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Growth Rate (2016-2021) (M Pcs) Figure 59. Russia Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 60. Asia Pacific Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Growth Rate 2016-2021 (M Pcs) Figure 61. Asia Pacific Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Growth Rate 2016-2021 (US$ Million) Figure 62. Asia Pacific Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Market Share by Region in 2020 Figure 63. Asia Pacific Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Market Share by Region in 2020 Figure 64. China Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Growth Rate (2016-2021) (M Pcs) Figure 65. China Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 66. Japan Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Growth Rate (2016-2021) (M Pcs) Figure 67. Japan Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 68. South Korea Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Growth Rate (2016-2021) (M Pcs) Figure 69. South Korea Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 70. India Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Growth Rate (2016-2021) (M Pcs) Figure 71. India Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 72. Australia Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Growth Rate (2016-2021) (M Pcs) Figure 73. Australia Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 74. Taiwan Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Growth Rate (2016-2021) (M Pcs) Figure 75. Taiwan Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 76. Indonesia Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Growth Rate (2016-2021) (M Pcs) Figure 77. Indonesia Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 78. Thailand Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Growth Rate (2016-2021) (M Pcs) Figure 79. Thailand Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 80. Malaysia Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Growth Rate (2016-2021) (M Pcs) Figure 81. Malaysia Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 82. Philippines Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Growth Rate (2016-2021) (M Pcs) Figure 83. Philippines Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 84. Vietnam Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Growth Rate (2016-2021) (M Pcs) Figure 85. Vietnam Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 86. Latin America Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Growth Rate 2016-2021 (M Pcs) Figure 87. Latin America Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Growth Rate 2016-2021 (US$ Million) Figure 88. Latin America Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Market Share by Country in 2020 Figure 89. Latin America Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Market Share by Country in 2020 Figure 90. Mexico Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Growth Rate (2016-2021) (M Pcs) Figure 91. Mexico Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 92. Brazil Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Growth Rate (2016-2021) (M Pcs) Figure 93. Brazil Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 94. Argentina Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Growth Rate (2016-2021) (M Pcs) Figure 95. Argentina Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 96. Middle East and Africa Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Growth Rate 2016-2021 (M Pcs) Figure 97. Middle East and Africa Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Growth Rate 2016-2021 (US$ Million) Figure 98. Middle East and Africa Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Market Share by Country in 2020 Figure 99. Middle East and Africa Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Market Share by Country in 2020 Figure 100. Turkey Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Growth Rate (2016-2021) (M Pcs) Figure 101. Turkey Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 102. Saudi Arabia Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Growth Rate (2016-2021) (M Pcs) Figure 103. Saudi Arabia Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 104. U.A.E Efavirenz/Lamivudine/Tenofovir Compound Drugs Sales Growth Rate (2016-2021) (M Pcs) Figure 105. U.A.E Efavirenz/Lamivudine/Tenofovir Compound Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 106. Efavirenz/Lamivudine/Tenofovir Compound Drugs Value Chain Figure 107. Channels of Distribution Figure 108. Distributors Profiles Figure 109. Bottom-up and Top-down Approaches for This Report Figure 110. Data Triangulation Figure 111. Key Executives Interviewed

Cipla Mylan MSD Pharmaceuticals Sun Pharmaceutical Industries Hetero Drugs